Company registration number 10422855 (England and Wales)
COVATIC LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
COVATIC LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
COVATIC LTD
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
3
659,611
712,825
Tangible assets
4
19,421
32,453
679,032
745,278
Current assets
Debtors
5
364,251
534,956
Cash at bank and in hand
67,268
832,181
431,519
1,367,137
Creditors: amounts falling due within one year
6
(913,170)
(635,461)
Net current (liabilities)/assets
(481,651)
731,676
Total assets less current liabilities
197,381
1,476,954
Creditors: amounts falling due after more than one year
7
(245,884)
(263,357)
Net (liabilities)/assets
(48,503)
1,213,597
Capital and reserves
Called up share capital
8
12,454
10,546
Share premium account
9,680,790
8,571,718
Other reserves
1,318,301
1,208,316
Profit and loss reserves
(11,060,048)
(8,576,983)
Total equity
(48,503)
1,213,597
COVATIC LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 30 September 2025 and are signed on its behalf by:
N PINKS
N  Pinks
Director
Company registration number 10422855 (England and Wales)
COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information

Covatic Ltd is a private company limited by shares incorporated in England and Wales. The registered office is c/o Browne Jacobson LLP, 15 Floor, 103 Colmore Row, Birmingham, United Kingdom, B3 3AG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements are prepared on the going concern basis. At the balance sheet date, the company had net current liabilities of £506,651. Included within these liabilities are amounts due to the directors and related undertakings of £73,000. The directors have taken steps to set up payment plans for various creditors and HMRC to ensure settlement of balances can be met at the agreed times. Further injections of cash via loans have also taken place post year end. Therefore, the financial statements are prepared on a going concern basis which assumes that the company will continue to meet its liabilities as they fall due. Furthermore, the directors have confirmed they shall continue to support the company to facilitate its ability to continue trading as a going concern for the foreseeable future. As a result, the directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future. true

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
10 years straight line
Development costs
10 years straight line
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% straight line
Computers
25-50% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade debtors and creditors. These are measured at amortised cost and are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

 

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

The company operates a defined contribution plan for it's employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations. The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.

1.14
Share-based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes option pricing model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.

 

Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

1.15
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
1.16
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
18
18
3
Intangible fixed assets
Patents & licences
Development costs
Total
£
£
£
Cost
At 1 January 2024
15,458
729,523
744,981
Additions - internally developed
9,557
-
9,557
At 31 December 2024
25,015
729,523
754,538
Amortisation and impairment
At 1 January 2024
1,429
30,727
32,156
Amortisation charged for the year
1,883
60,888
62,771
At 31 December 2024
3,312
91,615
94,927
Carrying amount
At 31 December 2024
21,703
637,908
659,611
At 31 December 2023
14,029
698,796
712,825
COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 January 2024
13,311
90,001
103,312
Additions
1,414
416
1,830
Disposals
(6,000)
-
(6,000)
At 31 December 2024
8,725
90,417
99,142
Depreciation and impairment
At 1 January 2024
8,014
62,845
70,859
Depreciation charged in the year
916
9,446
10,362
Eliminated in respect of disposals
(1,500)
-
(1,500)
At 31 December 2024
7,430
72,291
79,721
Carrying amount
At 31 December 2024
1,295
18,126
19,421
At 31 December 2023
5,297
27,156
32,453
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
117,251
274,090
Corporation tax recoverable
100,473
60,000
Other debtors
14,948
60,557
Prepayments and accrued income
131,579
140,309
364,251
534,956
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
1,400
17,500
Trade creditors
296,678
179,677
Taxation and social security
178,525
75,135
Other creditors
436,567
363,149
913,170
635,461

Included in Other borrowings is a loan from Creative Growth Finance Limited who hold a fixed charge and floating charge over all property or undertaking of the company.

COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other borrowings
245,884
261,957
Bank loans and overdrafts
-
1,400
245,884
263,357

Creative Growth Finance Limited hold a fixed charge and floating charge over all property or undertaking of the company.

8
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of 1p each
586,581
586,581
5,866
5,866
Ordinary A Shares of 1p each
56,250
56,250
563
563
Ordinary B Shares of 1p each
602,610
411,696
6,025
4,117
1,245,441
1,054,527
12,454
10,546

During the year, the convertible loan of £210,000 was converted to 30,468 ordinary shares of £0.01 each. The company also issued 168,107 ordinary B shares of £0.01 each for a total cash consideration of £1,544,903 and a further 995 ordinary shares of £0.01 each for a total cash consideration of £150,075.

9
Share-based payment transactions

The following share based payment arrangements were in existence during the year ended 31 December 2024.

Number of share options
Weighted average exercise price
2024
2023
2024
2023
Number
Number
£
£
Outstanding at 1 January 2024
271,234
343,490
5.56
8.64
Granted
-
39,766
-
0.01
Forfeited
-
(100,897)
0
-
8.64
Expired
-
(11,125)
0
-
8.64
Outstanding at 31 December 2024
271,234
271,234
5.56
5.56

The options outstanding at 31 December 2024 had an exercise price ranging from £0.01 to £8.00, and a remaining estimated life of up to 2 years.

COVATIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
9
Share-based payment transactions
(Continued)
- 9 -

The fair value of the options is estimated at the date of the grant using a Black-Scholes option pricing model. The following assumptions have been used in calculating the fair value of the share options.

Inputs were as follows:
2024
2023
Weighted average share price (pence)
893.00
893.00
Weighted average exercise price (pence)
556.00
556.00
Expected volatility (%)
44.00
44.00
Expected life (average years)
3.00
3.00
Risk free rate (%)
3.41
3.41

The risk free interest rate is based on the government gilt rate that is commensurate with the average expected life of the option. The expected life of the options is the expected average point at which an option becomes exercisable. The expected volatility is based on historical volatility of the share price of the Company and of quoted comparable companies over the most recent period at the date of the grant that is commensurate with the average expected life of the option. The weighted average share price was calculated using the black scholes option pricing model.

Liabilities and expenses

During the year, the company recognised total share-based payment expenses of £109,985 (2023 - £415,830) which related to equity settled share based payment transactions.

10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
Total commitments
64,785
85,690
11
Related party transactions

During the year, the company made repayments of £26,500 to a close relative of one of the directors, resulting in an outstanding loan balance due of £73,000 (2023 - £99,500). There are no set repayment terms, and interest is charged at 15% per annum on the outstanding amount due.

 

During the year, the company received £1,000 from directors and made repayments of £1,000 which resulted in an outstanding balance due to the directors at the year end of £NIL (2023 - £NIL). There are no set repayment terms, nor is interest charged on the outstanding amount due.

2024-12-312024-01-01falsefalsefalse30 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityT R EvansP W JohnsonS L JohnstonD E PikeN Pinks104228552024-01-012024-12-31104228552024-12-31104228552023-12-3110422855core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3110422855core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3110422855core:PatentsTrademarksLicencesConcessionsSimilar2023-12-3110422855core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3110422855core:FurnitureFittings2024-12-3110422855core:ComputerEquipment2024-12-3110422855core:FurnitureFittings2023-12-3110422855core:ComputerEquipment2023-12-3110422855core:WithinOneYear2024-12-3110422855core:WithinOneYear2023-12-3110422855core:AfterOneYear2024-12-3110422855core:AfterOneYear2023-12-3110422855core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3110422855core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3110422855core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3110422855core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3110422855core:ShareCapital2024-12-3110422855core:ShareCapital2023-12-3110422855core:SharePremium2024-12-3110422855core:SharePremium2023-12-3110422855core:OtherMiscellaneousReserve2024-12-3110422855core:OtherMiscellaneousReserve2023-12-3110422855core:RetainedEarningsAccumulatedLosses2024-12-3110422855core:RetainedEarningsAccumulatedLosses2023-12-3110422855core:ShareCapitalOrdinaryShareClass12024-12-3110422855core:ShareCapitalOrdinaryShareClass12023-12-3110422855core:ShareCapitalOrdinaryShareClass22024-12-3110422855core:ShareCapitalOrdinaryShareClass22023-12-3110422855core:ShareCapitalOrdinaryShareClass32024-12-3110422855core:ShareCapitalOrdinaryShareClass32023-12-3110422855core:ShareCapitalOrdinaryShares2024-12-3110422855core:ShareCapitalOrdinaryShares2023-12-3110422855bus:Director52024-01-012024-12-3110422855core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3110422855core:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3110422855core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3110422855core:FurnitureFittings2024-01-012024-12-3110422855core:ComputerEquipment2024-01-012024-12-31104228552023-01-012023-12-3110422855core:PatentsTrademarksLicencesConcessionsSimilar2023-12-3110422855core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-31104228552023-12-3110422855core:PatentsTrademarksLicencesConcessionsSimilarcore:InternallyGeneratedIntangibleAssets2024-01-012024-12-3110422855core:InternallyGeneratedIntangibleAssets2024-01-012024-12-3110422855core:FurnitureFittings2023-12-3110422855core:ComputerEquipment2023-12-3110422855bus:OrdinaryShareClass12024-01-012024-12-3110422855bus:OrdinaryShareClass22024-01-012024-12-3110422855bus:OrdinaryShareClass32024-01-012024-12-3110422855bus:OrdinaryShareClass12024-12-3110422855bus:OrdinaryShareClass12023-12-3110422855bus:OrdinaryShareClass22024-12-3110422855bus:OrdinaryShareClass22023-12-3110422855bus:OrdinaryShareClass32024-12-3110422855bus:OrdinaryShareClass32023-12-3110422855bus:AllOrdinaryShares2024-12-3110422855bus:AllOrdinaryShares2023-12-31104228552022-12-3110422855bus:PrivateLimitedCompanyLtd2024-01-012024-12-3110422855bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110422855bus:FRS1022024-01-012024-12-3110422855bus:AuditExemptWithAccountantsReport2024-01-012024-12-3110422855bus:Director12024-01-012024-12-3110422855bus:Director22024-01-012024-12-3110422855bus:Director32024-01-012024-12-3110422855bus:Director42024-01-012024-12-3110422855bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP